⌘K

Home/Filings/4/0001493152-24-025674

4//SEC Filing

Jafri Hasan 4

Accession 0001493152-24-025674

CIK 0001614067other

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 7:46 PM ET

Size

5.1 KB

Accession

0001493152-24-025674

Insider Transaction Report

Form 4

Period: 2024-06-27

Aridis Pharmaceuticals, Inc.ARDS

Chief Medical Officer

Transactions

Award
Stock options
2024-06-27+250,000→ 382,495 total
Exercise: $0.06From: 2024-06-27Exp: 2034-06-26→ Common Stock (250,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1

filerCIK 0001815352

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 7:46 PM ET
Size: 5.1 KB

View on SEC.gov